Impact of barrier precautions and antibiotic consumption on the incidence rate of acquired cases of infection or colonization with Acinetobacter baumannii: A 10-year multi-department study

American Journal of Infection Control

Volumn 39, Issue 10, 2011, Pages 891-894

  Lefebvre, Annick ^a   Gbaguidi Haore, Houssein ^a,b,c   Bertrand, Xavier ^a,b,c   Thouverez, Michelle ^a,b,c   Talon, Daniel ^a,b,c  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c INSERM   (France)

Author keywords

Acinetobacter baumannii; antibiotic consumption; barrier precautions; generalized estimating equations model; multidrug resistance; random effects model

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC CONSUMPTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; CLINICAL EFFECTIVENESS; DRUG USE; HOSPITAL DEPARTMENT; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; NONHUMAN;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; ASYMPTOMATIC DISEASES; DRUG UTILIZATION; FLUOROQUINOLONES; FRANCE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE;

EID: 82655172625     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2011.01.009     Document Type: Article

References (11)

1. A.Y. Peleg, H. Seifert, and D.L. Paterson Acinetobacter baumannii: emergence of a successful pathogen Clin Microbiol Rev 21 2008 538 582
2. F. Perez, A.M. Hujer, K.M. Hujer, B.K. Decker, P.N. Rather, and R.A. Bonomo Global challenge of multidrug-resistant Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 3471 3484 (Pubitemid 47519332)
3. K.J. Towner Acinetobacter: an old friend, but a new enemy J Hosp Infect 73 2009 355 363
4. A. Jawad, H. Seifert, A.M. Snelling, J. Heritage, and P.M. Hawkey Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates J Clin Microbiol 36 1998 1938 1941 (Pubitemid 28277780)
5. B. Mulin, D. Talon, J.F. Viel, C. Vincent, R. Leprat, and M. Thouverez Risk factors for nosocomial colonization with multiresistant Acinetobacter baumannii Eur J Clin Microbiol Infect Dis 14 1995 569 576
6. H. Gbaguidi-Haore, S. Legast, M. Thouverez, X. Bertrand, and D. Talon Ecological study of the effectiveness of isolation precautions in the management of hospitalized patients colonized or infected with Acinetobacter baumannii Infect Control Hosp Epidemiol 29 2008 1118 1123
7. WHO Collaborating Centre for Drug Statistics Methodology Guidelines for ATC classification and DDD assignment 2009 Norwegian Institute of Public Health Oslo, Norway
8. M.E. Falagas, and P. Kopterides Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature J Hosp Infect 64 2006 7 15 (Pubitemid 44161380)
9. R. Valencia, L.A. Arroyo, M. Conde, J.M. Aldana, M.J. Torres, and F. Fernandez-Cuenca Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital Infect Control Hosp Epidemiol 30 2009 257 263
10. D. Villers, E. Espaze, M. Coste-Burel, F. Giauffret, E. Ninin, and F. Nicolas Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology Ann Intern Med 129 1998 182 189 (Pubitemid 28377507)
11. M. Souli, I. Galani, and H. Giamarellou Emergence of extensively drug-resistant and pandrug-resistant gram-negative bacilli in Europe Eur Surveill 2008 13 Available at: http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId=19045